The immunopathogenesis of hepatitis C virus infection (Q34422751)

2 August 2017

1 reference

title

The immunopathogenesis of hepatitis C virus infection (English)

1 reference

2 August 2017

1 reference

1 reference

Nelson DR

1

1 reference

2 August 2017

publication date

1 November 2001

1 reference

2 August 2017

published in

Clinics in liver disease

1 reference

2 August 2017

volume

5

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

931-953

1 reference

Bystander activation by cytokines of intrahepatic T cells in chronic viral hepatitis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

HLA class II genes determine the natural variance of hepatitis C viral load

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Regulation of monocyte interleukin-12 production by acute alcohol: a role for inhibition by interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Increase in CD5+ B cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Transgenic expression of hepatitis C virus structural proteins in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Blunted anti-inflammatory response to adenosine in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Lymphocyte subsets in HCV-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Hepatitis C serotypes in nonalcoholic and alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

A natural killer cell granule protein that induces DNA fragmentation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970202-6

7 January 2021

10.1016/S1089-3261(05)70202-6

Identifiers

DOI

1 reference

2 August 2017

1 reference